1 / 39

ASCITES Cengiz Pata Gastroenterology Department Yeditepe University, Istanbul

. ASCITES Cengiz Pata Gastroenterology Department Yeditepe University, Istanbul.

keilah
Download Presentation

ASCITES Cengiz Pata Gastroenterology Department Yeditepe University, Istanbul

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. . ASCITESCengiz PataGastroenterology DepartmentYeditepe University, Istanbul

  2. Cirrhosis is the late result of any disease that causes scarring of the liver. Patients with cirrhosis are susceptible to a variety of complications that include ascites, hepatic encephalopathy, and portal hypertension. Quality of life and survival are often improved by the prevention and treatment of these complications.

  3. Ascitesis defined as the accumulation of free fluid in the peritoneal cavity.It is a common clinical finding with a variety of both extraperitoneal and peritoneal etiologies. It is most often caused liver cirrhosis 75% malignancy (10%) heart failure (3%) pancreatitis (1%) TB (2%), or other rare causes.

  4. Nonperitoneal Causes of Ascites

  5. Peritoneal Causes of Ascites

  6. PrognosisThe development of ascites is an indication of deterioration in clinical status and poor prognosis. Prognosis is worse for those with refractory ascites and SBP.Approximately 60% of patients with cirrhosis will develop ascites requiring therapy and/or liver transplantation in 10 years duration. Mortality in cirrhotic patients hospitalized with ascites is 40% at 2 years.

  7. PATHOPHYSIOLOGY

  8. The pathogenesis of ascites formation remains controversial. “Underfill" theory Ascites occurs as a primary event.Sequestration of fluid into the peritoneal cavity as a result of changes in Starling's forces leads to reduction of the circulatory volume and stimulation of the sympathetic nervous & RAAS that promote renal sodium & water retention.

  9. “Overflow theory" Renal Na retention occurs as a primary event.It may be due to increased production of a sodium retaining factor or reduced synthesis of a natriuretic factor by the diseased liver. The circulatory volume is expanded & the retained fluid is preferentially localized to the peritoneal cavity as ascites.

  10. The currently accepted theory of ascites formation which include features of both the underfill and overflow theories is the “Peripheral Arterial Vasodilation Hypothesis" According to this theory, Portal pressure >12 mm Hg is required for the development of PH which will lead to formation of ascites.

  11. As PH develops, vasodilators are released affecting the splanchnic arteries resulting in decrease in effective arterial blood flow and arterial pressures .The precise agent (or agents) responsible for vasodilation is a subject of wide debate; however, most recent literature has focused on the role of: Nitric Oxide

  12. Chronic endotoxemia associated with cirrhosis may stimulate the synthesis and release of a potent endothelin-derived relaxing factor, Nitric oxide. NO is the likely mediator in cirrhosis:(1) Increased activity of NO synthase .(2) High serum nitrite and nitrate levels (an index of NO synthesis). (3) Inhibition of NO leads to increased arterial pressures and systemic vascular resistance.

  13. Portal hypertensionVasodilatation, Decrease Splanchnic Systemic vascular resistance Reduction in arterial blood volumeActivation of neurohumoral pressor systemsRenal sodium & water retention

  14. When Na reabsorption cannot compensate for vasodilation, arterial underfillingleads to further activation of vasoconstrictor & antinatriuretic mechanisms which leads to increased Na retention & ultimately ascites is formed. In the late stages of cirrhosis, free water accumulation is more pronounced than the Na retention leading to dilutional hyponatremia.

  15. DIAGNOSIS

  16. I) History

  17. II) Physical Examination

  18. The older system 1+ is minimal and barely detectable. 2+ is moderate. 3+ is massive but not tense. 4+ is massive and tense. The International Ascites Club grading (2003)Grade 1: mild ascites detectable only by US. Grade 2: moderate ascites manifested by moderate symmetrical abdominal distension. Grade 3: large or gross ascites with marked abdominal distension.

  19. III) Diagnostic ParacentesisIndications(1)Evaluation for a non-cirrhotic patient developing clinically apparent ascites of recent onset. (2)New development of ascites in a cirrhotic patient does not routinely require paracentesis only if :(a) General condition deteriorates.(b) In presence of unexplained fever, abdominal pain, encephalopathy.(c) Admission to hospital for any cause (SBP).(3)Laboratory investigations indicating infection: Leucocytosis Acidosis Worsening of renal functions

  20. SiteMidline was usually chosen. Abdominal wall in the left lower quadrant, 2 finger breadths cephalic & 2 finger breadths medial to ASIS, has been shown to be thinner with larger pool of fluid than midline. Complications(1% of patients) -Abdominal wall hematomas. -Hemoperitoneum or bowel entry.ContraindicationsClinically evident fibrinolysis or DIC.

  21. Gross Appearance of Ascitic Fluid

  22. Ascitic Fluid Testing

  23. Ascitic fluid analysis (Routine)I) Cell count with differentialAbnormal results are an indication for further non routine tests. If the PMN count is >250 cells/mm3, another specimen is injected into blood culture bottles at bedside. Bacterial growth occurs in about 80% of specimens with count of >250 cells/mm3. The PMN count is calculated by multiplying the white cells/mm3 by the percentage of neutrophils in the differential.

  24. In a "bloody" sample that contains a high concentration of RBC, the PMN count must be corrected: one PMN is subtracted from the absolute PMN count for every 250 red cells/mm3 in the sample.The results must be available within 1 hour, so that important diagnostic and therapeutic decisions can be made.A Gram stain is of particular low yield unless free gut perforation, is suspected.

  25. II)Total protein ,albumin & serum albumin .Serum-ascites albumin gradient (SAAG) = serum albumin - ascitic fluid albumin. If > 1.1 g/dL, the patient has PH-related ascites. If < 1.1 g/dL (about 97% accurate), the patient does not have PH-related ascites. The SAAG does not need to be repeated after the initial measurement.

  26. III)Based on clinical judgment, additional testing can be performed : a) Cytology ,smear & culture for mycobacteriab) Cytology : in peritoneal carcinomatosis (sensitivity increased by centrifuging large volume). c) Elevated bilirubin level suggest biliary or gut perforation. d) LDH >225mU/L, glucose <50mg/dL, total protein >1g/dL and multiple organisms on gram stain suggest secondary bacterial peritonitis. e) High level of TG's confirms chylous ascites. f) Elevated amylase level suggest pancreatitis or gut perforation.

  27. AASLD Recommendations1.Paracentesis should be performed ,ascitic fluid should be obtained from inpatients & outpatients with clinically apparent new-onset ascites2. Since bleeding is uncommon ,prophylactic use of FFP or platelets is not recommended. 3. Initial evaluation of ascitic fluid should include cell count ,differential, total protein & SAAG.4. If infection is suspected, ascitic fluid should be cultured at the bedside in blood culture bottles.5. Other studies can be ordered based on pretest probability of disease.

  28. Cirrhotic Ascites • The management of all complications of uninfected cirrhotic ascites (pleural effusions, abdominal wall hernias, etc.) begins with salt restriction (2g. or less) and diuretics (generally a combination of spironolactone and furosemide) • Fluid restriction is only indicated for marked hyponatremia • Only 10% of cirrhotic patients have truly refractory ascites

  29. treatment

  30. Refractory Ascites • A definition: “failure to lose 200g of weight in a patient despite severe Na restriction (50 meq/day) and maximal doses of loop diuretic (e.g. 160mg/d Lasix) and distal tubule diuretic (e.g. 400mg/d Aldactone)” Arroyo V et al, Hepatology 1996;23:164-76 • 50% 6-month mortality

  31. Management: Refractory Ascites • Repeat large-volume paracentesis (LVP), coupled with infusion of 6-8 grams of IV albumin per liter of ascites removed, is first-line • TIPS: only in patients who require serial LVP, and have CTP score of <12

  32. TIPS (Transjugular Intrahepatic Portosystemic Shunt)

  33. TIPS for Refractory Ascites • Controversial, since TIPS may complicate subsequent transplantation • In uncontrolled studies, 50-90% of subjects were noted to become ascites-free after TIPS placement • In controlled studies, TIPS controls ascites better than LVP except in Child’s C cirrhotics Rossle et al, NEJM 2000;342:1701-07 • No mortality improvement for TIPS over LVP, and TIPS may increase mortality in Child’s C

  34. Risk for Dying with TIPS • Serum bilirubin >3mg/dl • INR >2 • Creatinine > 2 mg/dl Malinchoc et al Hepatology 2000;31:864-71 • Other relative TIPS contraindications: severe pre-TIPS encephalopathy, pulmonary hypertension or heart failure • Paracentesis + albumin is first-line

  35. Ascites infections • Sbp • CNBA • NNBA • Secondary peritonites

  36. diagnosis

  37. Spontaneous Bacterial Peritonitis(S.B.P.) • A diagnostic paracentesis should be performed in all cirrhotics with ascites who: 1)are admitted to the hospital, 2) have signs/symptoms, 3)worsened renal/liver function • Dx: ascites PMN count >250/mm3 Rimola A, et al. J Hepatol 2000;32:142-153 • Tx: Third generation cephalosporin, IV Augmentin for 5-10 days (PMN <250/mm3) • Diuretics and large-volume paracentesis: hold until resolution of S.B.P.

  38. Secondary S.B.P. Prophylaxis • 1-year recurrence of S.B.P. is 70% • Secondary prophylaxis with any ascites • Norfloxacin 400mg qd (VA: Ciprofloxacin 250mg po qd) is first-line prophylaxis against recurrence • Bactrim DS 5 days/wk, Ciprofloxacin 750mg q week are second-line alternatives, but have not been as well-studied

More Related